Status: Not yet recruiting
Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence
The purpose of this study is to assess the clinical efficacy of the LCPT En-varsus \[Life-Cycle Pharma Tacrolimus\] initiated in de novo (Day 0 of transplantation) using the Biopsy Proven Acute Re-jection and iBox (full and abbreviated algo-rithms).
Participants needed: 165
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Chiesi SASUpdated: May 7, 2025Locations: 1
Eligibility criteria
Kidney recipients aged 18 years and older. [+4]
Contraindications to the use of Life-Cycle Pharma Tacrolimus (Envarsus®). [+10]